Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
暂无分享，去创建一个
H. Kerstjens | C. Gessner | R. V. van Zyl-Smit | M. Hosoe | A. Pethe | P. D’Andrea | O. Kornmann | E. Scosyrev | D. Brittain | E. Aubrun | Devendra Jain | Motoi Hosoe